Advanced Breast Cancer Therapies
Topics
Description: This cluster of papers focuses on the use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, such as palbociclib, letrozole, ribociclib, and abemaciclib, in the treatment of hormone receptor-positive... more
Related topics (siblings) Abdominal Surgery and Complications, Aortic aneurysm repair treatments, Aortic Disease and Treatment Approaches, Aortic Thrombus and Embolism, Automotive and Human Injury Biomechanics +46 more
Subfield (parent): Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Works count: 25,390
Citations count: 189,600
Palbociclib and Letrozole in Advanced Breast Cancer
2016 · Richard S. Finn, Miguel Martín, et al. · New England Journal of Medicine
Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 · Fabrice André, Eva Ciruelos, et al. · New England Journal of Medicine
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
2016 · Fátima Cardoso, A. Costa, et al. · Annals of Oncology